Summary
You must systematically evaluate and manage the risks associated with deploying your medical device software in customer environments to ensure safe and effective operation throughout the deployment lifecycle. Deployment activities assess infrastructure complexity, establish installation procedures, implement monitoring systems, and document successful deployment to maintain device safety and performance in real-world environments.Regulatory Context
- FDA
- MDR
Under 21 CFR Part 820 (Quality System Regulation), you must implement:
- Design validation per Section 820.30(g) confirming device performance in intended use environment
- Installation and servicing per Section 820.200 ensuring controlled deployment procedures
- Change control per Section 820.40 for deployment configuration management
- Post-market surveillance per Section 820.100 monitoring deployment performance
- Cybersecurity management per FDA guidance for networked device deployment